Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Personalized chronic adaptive deep brain stimulation outperforms conventional stimulation in Parkinson's disease.
Oehrn CR, Cernera S, Hammer LH, Shcherbakova M, Yao J, Hahn A, Wang S, Ostrem JL, Little S, Starr PA. Oehrn CR, et al. Among authors: ostrem jl. medRxiv [Preprint]. 2023 Aug 8:2023.08.03.23293450. doi: 10.1101/2023.08.03.23293450. medRxiv. 2023. Update in: Nat Med. 2024 Aug 19. doi: 10.1038/s41591-024-03196-z. PMID: 37649907 Free PMC article. Updated. Preprint.
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.
Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT. Marks WJ Jr, et al. Among authors: ostrem jl. Lancet Neurol. 2008 May;7(5):400-8. doi: 10.1016/S1474-4422(08)70065-6. Epub 2008 Apr 2. Lancet Neurol. 2008. PMID: 18387850 Clinical Trial.
150 results